about
Wound healing revised: a novel reepithelialization mechanism revealed by in vitro and in silico models.Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.TTCA: an R package for the identification of differentially expressed genes in time course microarray dataUVB-regulated gene expression in human keratinocytes. Analysis by differential display.Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma.Stathmin regulates keratinocyte proliferation and migration during cutaneous regeneration.Cytosolic and nuclear caspase-8 have opposite impact on survival after liver resection for hepatocellular carcinoma.SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice.Directed random walks and constraint programming reveal active pathways in hepatocyte growth factor signaling.Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.Tumor cell load and heterogeneity estimation from diffusion-weighted MRI calibrated with histological data: an example from lung cancer.On the ontology based representation of cell lines.Dysregulation of growth factor signaling in human hepatocellular carcinoma.Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.High-fat intake during pregnancy and lactation exacerbates high-fat diet-induced complications in male offspring in mice.Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC).Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress.PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches.Transcriptional regulators in hepatocarcinogenesis--key integrators of malignant transformation.Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer.Inducing Differentiation of Premalignant Hepatic Cells as a Novel Therapeutic Strategy in Hepatocarcinoma.Cellular apoptosis susceptibility (CAS) is overexpressed in thyroid carcinoma and maintains tumor cell growth: A potential link to the BRAFV600E mutation.Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells.Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.Quantitative and integrative analysis of paracrine hepatocyte activation by nonparenchymal cells upon lipopolysaccharide induction.Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells.Nuclear accumulation of seven in absentia homologue-2 supports motility and proliferation of liver cancer cells.The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.AP-1-controlled hepatocyte growth factor activation promotes keratinocyte migration via CEACAM1 and urokinase plasminogen activator/urokinase plasminogen receptor.Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis.Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference.Nucleoporin 88 expression in hepatitis B and C virus-related liver diseases.Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
P50
Q30557891-83498728-F083-49BF-8508-967ECF93B3C0Q31132600-4E84341D-E761-4DC7-A54D-3159F0CC415EQ31154706-BEE5F772-F2A4-4EE2-BC5C-07B3E7A0052EQ33979245-2E690208-7E62-416D-9D7A-9700EC19F5A4Q34146004-D9EEEC3F-213C-4A3C-9D19-C66513F727E4Q34352254-54D70556-F8AB-4AB8-B391-68C2F7C07FAAQ34997445-BA27DA18-61AD-4662-AAFB-45A4BE9E53E7Q35037566-8F6F79DB-FB7B-46E1-BEFA-F255F79BA72FQ35273519-5353F7CD-34DD-40BB-B4D7-9F2D20CB290AQ35827698-25AA13D2-F449-4473-8CAD-79F1AAE56DEDQ35977804-7AA1B270-2892-4E59-A1A2-4C8DAF4B78ACQ36360404-D2EE022A-CFB2-4477-BC1B-69F6AA2EEC06Q36381139-928365AB-C56C-430B-B812-0E94455789E8Q36519010-205CAAAF-C8A2-4895-86E0-2F4153DED171Q37113552-8E269C4D-B9A9-4AC3-AB58-1F27BC792F59Q37181869-F3A439A7-F3C3-4891-AA85-ACF77AD8369AQ37225702-020219DC-E69E-4D8E-8353-B5AE4D768D65Q37603281-70963372-832E-42D5-A404-69C9A3B1F7AAQ37603821-D41A9E9F-3FFF-4213-92A3-776564E73C6EQ37857056-AA59BEAC-D22F-41B0-B9AD-6C05C5C101F4Q37996824-04D75C5E-391F-44E6-A329-1E9684E4B626Q38726803-62804BDD-A4EF-4E2E-ADE5-E8CF10716B4EQ38753989-CA950674-CDD1-4B9F-8F38-D7ECC98F9889Q38792834-9AADE020-B497-496E-A860-60040C64D0EFQ38852692-EC1F3920-16AF-407A-B4E1-076248A3DD8EQ38935135-80803B65-FF28-49AF-AF36-3B9A49E1DA21Q39008508-ACB57FAD-CA6F-4FFA-A1B7-7F582884E3A6Q39009644-5FA9F384-EA61-483C-8D34-644274145C50Q39100509-43D23CA7-65C9-4977-B4D7-3E85693B1589Q39310720-BBF752FD-2B17-4753-AA9F-E2FECC989252Q39397418-8EE998A4-2D6B-4CFC-AC0E-76AEB204D74FQ39398502-2FCD4E18-2BA3-4D49-A399-8C82C09C5AF7Q39433431-0ABB9C6A-087D-4B3C-AC0C-83DED8592886Q39585192-E5A6AD73-A8EE-4FA7-9039-4885BEE55998Q39814040-83FB8B90-A738-4D3D-8AE7-265B90BC16A5Q39914535-E96EBD12-BCA9-47C1-9BD5-CC3B31F1B9C7Q40100660-3C263298-33D5-4B93-A0C2-B0F6F0C8B241Q40112374-64FAA6B4-B34C-4219-AA36-56B2DBC283F3Q40226496-716BD19F-5CA5-45E3-A34F-B2FC95A21627Q40254044-DF4BE10B-469C-4ACE-8886-4DF2C94677DB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Kai Breuhahn
@ast
Kai Breuhahn
@en
Kai Breuhahn
@es
Kai Breuhahn
@sl
type
label
Kai Breuhahn
@ast
Kai Breuhahn
@en
Kai Breuhahn
@es
Kai Breuhahn
@sl
prefLabel
Kai Breuhahn
@ast
Kai Breuhahn
@en
Kai Breuhahn
@es
Kai Breuhahn
@sl
P214
P227
P106
P21
P214
P227
P2798
P31
P496
0000-0002-2462-1229
P569
1969-01-01T00:00:00Z
P735
P7859
viaf-13200464